An oncology drug “strategic reserve” could be a long-term solution to chronic shortages of critical cancer medicines in the US, FDA Oncology Center of Excellence Director Richard Pazdur suggested during a Friends of Cancer Research workshop last month.
While carefully noting that he cannot advocate for legislative changes, Pazdur described the stockpile as an idea that the “oncology...